Invention Grant
- Patent Title: Crystallization of 4′-epidaunorubicin hydrochloride
- Patent Title (中): 4'-表柔比星盐酸盐结晶
-
Application No.: US13394738Application Date: 2010-09-08
-
Publication No.: US08686164B2Publication Date: 2014-04-01
- Inventor: Tero Kunnari , Holger Bindernagel , Sascha Weiser , Andrew Lupton , Stefan Wallert
- Applicant: Tero Kunnari , Holger Bindernagel , Sascha Weiser , Andrew Lupton , Stefan Wallert
- Applicant Address: DE Hanau
- Assignee: Heraeus Precious Metals GmbH & Co. KG
- Current Assignee: Heraeus Precious Metals GmbH & Co. KG
- Current Assignee Address: DE Hanau
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Priority: EP09011459 20090908
- International Application: PCT/EP2010/005498 WO 20100908
- International Announcement: WO2011/029576 WO 20110317
- Main IPC: C07D315/00
- IPC: C07D315/00

Abstract:
4′-epidaunorubicin hydrochloride is provided in a crystalline form which is stable and readily soluble. A process of producing the crystalline form includes crystallizing 4′-epidaunorubicin hydrochloride in a solvent system including (a) solvent A selected from C1 and C2 halogenated solvents and mixtures thereof, (b) solvent B selected from C1-C5 straight and branched alcohols and mixtures thereof, and (c) solvent C selected from C1-C5 straight and branched alcohols and mixtures thereof, wherein solvent C is selected to provide lower solubility to 4′-epidaunorubicin hydrochloride than solvent B.
Public/Granted literature
- US20120232291A1 CRYSTALLIZATION OF 4'-EPIDAUNORUBICIN X HCI Public/Granted day:2012-09-13
Information query